Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aditxt ( (ADTX) ) just unveiled an announcement.
On February 13, 2026, Aditxt’s shareholders approved a reverse stock split at a special meeting, after which the board set the ratio at 1-for-8 and the company filed an amendment to its certificate of incorporation in Delaware on March 5, 2026. The reverse split becomes effective at 4:01 p.m. Eastern Time on March 6, 2026, with Aditxt’s common stock, now carrying CUSIP 007025877, set to begin trading on a split-adjusted basis on Nasdaq under the existing ADTX ticker on March 9, 2026.
Under the 1-for-8 reverse split, every eight shares of issued and outstanding common stock will be converted into one share, fractional shares will be rounded up, and the company will have approximately 517,856 shares outstanding immediately after effectiveness. The move is primarily intended to restore compliance with Nasdaq’s minimum bid price requirement, with proportional adjustments also being applied to outstanding stock options, restricted stock units, warrants, and shares reserved under Aditxt’s equity incentive plans, while shareholders holding in book-entry or through intermediaries are not required to take action.
More about Aditxt
Aditxt, Inc. is a social innovation platform focused on accelerating promising health innovations. The company leverages an ecosystem of research institutions, industry partners, and shareholders to pursue a multi-disciplinary model that aims to democratize innovation and address significant societal challenges in the healthcare space.
Average Trading Volume: 2,219,259
Technical Sentiment Signal: Strong Sell
Current Market Cap: $261.3K
Find detailed analytics on ADTX stock on TipRanks’ Stock Analysis page.